FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1990978845> ?p ?o ?g. }

• W1990978845 endingPage "236" @default.
• W1990978845 startingPage "227" @default.
• W1990978845 abstract "OBJECTIVE--To study the effects of adding a salicylate to the angiotensin converting enzyme inhibitor enalapril in patients with heart failure due to coronary artery disease. DESIGN--Double blind, crossover study for three days in hospital followed by an extended similar study outside hospital over two months of once daily enalapril plus salicylate and enalapril plus placebo. SETTING--Tertiary referral centre. PATIENTS--20 patients with heart failure due to myocardial infarction (New York Heart Association class II or III) and an ejection fraction less than 0.40. Twelve patients completed the two parts of the study. MAIN OUTCOME MEASURES--Blood pressure, plasma converting enzyme activity; plasma angiotensin II and noradrenaline concentrations; excretion of metabolites of renal and systemic prostanoids. RESULTS--The unloading effect of first and second dose of enalapril in the morning lasted only during the day; in the extended study it lasted 24 hours because of the drug9s accumulation. Converting enzyme inhibitors attenuate the breakdown of bradykinin and therefore enhance prostaglandin E2 synthesis mediated by bradykinin. Evidence was found of such a prostaglandin E2 mediated contribution to ventricular unloading by enalapril, which was blocked by salicylate. The contribution, however, was small and variable, and salicylate addition had on average no significant de-unloading effect during the day. Unloading was abolished in only three of the 20 patients in the short term study and in one of the 12 in the extended study. At night, when other effects of enalapril on blood pressure had waned and the bradykinin induced effect persisted, salicylate significantly reduced the remaining small unloading effect. No effect was seen of salicylate addition on reversal of remodelling. Enalapril reduced angiotensin II induced synthesis of systemic and renal prostaglandin I2 and thromboxane A2, initially only during the day, but later also at night. It thereby masked suppression of thromboxane A2 synthesis by salicylate, which is the effect to which reinfarct prevention by salicylate is attributed. CONCLUSION--The risk is low that salicylate will substantially reduce the benefit of enalapril in patients with heart failure by de-unloading the ventricle. Like other effects induced by bradykinin significant de-unloading occurs in only a minority of the patients. In the presence of enalapril, however, salicylate will probably not be as effective as expected in reducing reinfarction risk, because enalapril already reduces thromboxane A2 synthesis effectively in patients with heart failure and no further reduction by salicylate was found." @default.
• W1990978845 created "2016-06-24" @default.
• W1990978845 creator A5001010886 @default.
• W1990978845 creator A5006137371 @default.
• W1990978845 creator A5018249044 @default.
• W1990978845 creator A5021827495 @default.
• W1990978845 creator A5024455780 @default.
• W1990978845 creator A5026757285 @default.
• W1990978845 creator A5032704755 @default.
• W1990978845 creator A5068374622 @default.
• W1990978845 creator A5068784109 @default.
• W1990978845 creator A5088784768 @default.
• W1990978845 date "1995-03-01" @default.
• W1990978845 modified "2023-10-03" @default.
• W1990978845 title "Combining salicylate and enalapril in patients with coronary artery disease and heart failure." @default.
• W1990978845 cites W1911188572 @default.
• W1990978845 cites W1968798753 @default.
• W1990978845 cites W1972872979 @default.
• W1990978845 cites W1986836843 @default.
• W1990978845 cites W1993288716 @default.
• W1990978845 cites W1997218037 @default.
• W1990978845 cites W2009628393 @default.
• W1990978845 cites W2009924885 @default.
• W1990978845 cites W2013769068 @default.
• W1990978845 cites W2020929639 @default.
• W1990978845 cites W2033565692 @default.
• W1990978845 cites W2041718175 @default.
• W1990978845 cites W2046383587 @default.
• W1990978845 cites W2047528269 @default.
• W1990978845 cites W2049691991 @default.
• W1990978845 cites W2055446183 @default.
• W1990978845 cites W2075522477 @default.
• W1990978845 cites W2093066000 @default.
• W1990978845 cites W2138806344 @default.
• W1990978845 cites W2154399730 @default.
• W1990978845 cites W2156026923 @default.
• W1990978845 cites W2171083892 @default.
• W1990978845 cites W2230839054 @default.
• W1990978845 cites W2403250230 @default.
• W1990978845 cites W2429887863 @default.
• W1990978845 cites W2585382523 @default.
• W1990978845 cites W4239471829 @default.
• W1990978845 doi "https://doi.org/10.1136/hrt.73.3.227" @default.
• W1990978845 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/483803" @default.
• W1990978845 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/7727181" @default.
• W1990978845 hasPublicationYear "1995" @default.
• W1990978845 type Work @default.
• W1990978845 sameAs 1990978845 @default.
• W1990978845 citedByCount "57" @default.
• W1990978845 countsByYear W19909788452013 @default.
• W1990978845 countsByYear W19909788452017 @default.
• W1990978845 crossrefType "journal-article" @default.
• W1990978845 hasAuthorship W1990978845A5001010886 @default.
• W1990978845 hasAuthorship W1990978845A5006137371 @default.
• W1990978845 hasAuthorship W1990978845A5018249044 @default.
• W1990978845 hasAuthorship W1990978845A5021827495 @default.
• W1990978845 hasAuthorship W1990978845A5024455780 @default.
• W1990978845 hasAuthorship W1990978845A5026757285 @default.
• W1990978845 hasAuthorship W1990978845A5032704755 @default.
• W1990978845 hasAuthorship W1990978845A5068374622 @default.
• W1990978845 hasAuthorship W1990978845A5068784109 @default.
• W1990978845 hasAuthorship W1990978845A5088784768 @default.
• W1990978845 hasBestOaLocation W19909788451 @default.
• W1990978845 hasConcept C126322002 @default.
• W1990978845 hasConcept C134018914 @default.
• W1990978845 hasConcept C138976137 @default.
• W1990978845 hasConcept C164705383 @default.
• W1990978845 hasConcept C170493617 @default.
• W1990978845 hasConcept C198710026 @default.
• W1990978845 hasConcept C27016395 @default.
• W1990978845 hasConcept C2775940317 @default.
• W1990978845 hasConcept C2778198053 @default.
• W1990978845 hasConcept C2778213512 @default.
• W1990978845 hasConcept C2779591629 @default.
• W1990978845 hasConcept C500558357 @default.
• W1990978845 hasConcept C71924100 @default.
• W1990978845 hasConcept C78085059 @default.
• W1990978845 hasConcept C84393581 @default.
• W1990978845 hasConceptScore W1990978845C126322002 @default.
• W1990978845 hasConceptScore W1990978845C134018914 @default.
• W1990978845 hasConceptScore W1990978845C138976137 @default.
• W1990978845 hasConceptScore W1990978845C164705383 @default.
• W1990978845 hasConceptScore W1990978845C170493617 @default.
• W1990978845 hasConceptScore W1990978845C198710026 @default.
• W1990978845 hasConceptScore W1990978845C27016395 @default.
• W1990978845 hasConceptScore W1990978845C2775940317 @default.
• W1990978845 hasConceptScore W1990978845C2778198053 @default.
• W1990978845 hasConceptScore W1990978845C2778213512 @default.
• W1990978845 hasConceptScore W1990978845C2779591629 @default.
• W1990978845 hasConceptScore W1990978845C500558357 @default.
• W1990978845 hasConceptScore W1990978845C71924100 @default.
• W1990978845 hasConceptScore W1990978845C78085059 @default.
• W1990978845 hasConceptScore W1990978845C84393581 @default.
• W1990978845 hasIssue "3" @default.
• W1990978845 hasLocation W19909788451 @default.
• W1990978845 hasLocation W19909788452 @default.
• W1990978845 hasLocation W19909788453 @default.
• W1990978845 hasLocation W19909788454 @default.

• next